Sign in
4

Changes in Ownership

Teladoc Health, Inc. Filed Acc 0001179110-20-011987

Head of Research & Development sold 2,500 shares at $199.24 ($498,100)

  • Head of Research & Development acquired 7,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WANG YULUN · Head of Research & Development

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-14 Exercise or conversion : show line 1 in the form +2,500 $16.92 $42,300 2,500 D
2020-12-14 Sale : show line 2 in the form −2,500 $199.24 $498,100 0 D
2020-12-15 Exercise or conversion : show line 3 in the form +4,500 $16.92 $76,140 4,500 D
Open-market sales · 2,500 sh · avg $199.24 · $498,100

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-12-14 Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) −2,500 57,365 D
2020-12-15 Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) −4,500 52,865 D
Loading xslF345X03/edgar.xml…